Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 5
2009 5
2010 9
2011 7
2012 4
2013 7
2014 6
2015 13
2016 10
2017 13
2018 13
2019 20
2020 22
2021 23
2022 18
2023 25
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration.
Molina-Gonzalez I, Holloway RK, Jiwaji Z, Dando O, Kent SA, Emelianova K, Lloyd AF, Forbes LH, Mahmood A, Skripuletz T, Gudi V, Febery JA, Johnson JA, Fowler JH, Kuhlmann T, Williams A, Chandran S, Stangel M, Howden AJM, Hardingham GE, Miron VE. Molina-Gonzalez I, et al. Among authors: skripuletz t. Nat Commun. 2023 Jun 8;14(1):3372. doi: 10.1038/s41467-023-39046-8. Nat Commun. 2023. PMID: 37291151 Free PMC article.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders.
Konen FF, Möhn N, Witte T, Schefzyk M, Wiestler M, Lovric S, Hufendiek K, Schwenkenbecher P, Sühs KW, Friese MA, Klotz L, Pul R, Pawlitzki M, Hagin D, Kleinschnitz C, Meuth SG, Skripuletz T. Konen FF, et al. Among authors: skripuletz t. Autoimmun Rev. 2023 May;22(5):103312. doi: 10.1016/j.autrev.2023.103312. Epub 2023 Mar 15. Autoimmun Rev. 2023. PMID: 36924922 Free article. Review.
[Neuroimmunology of COVID-19].
Skripuletz T, Möhn N, Franke C, Prüß H. Skripuletz T, et al. Nervenarzt. 2021 Jun;92(6):521-530. doi: 10.1007/s00115-021-01077-1. Epub 2021 Mar 2. Nervenarzt. 2021. PMID: 33651117 Free PMC article. Review. German.
Sjögren's syndrome with and without neurological involvement.
Seeliger T, Kramer E, Konen FF, Zehrfeld N, Beider S, Prenzler NK, Gödecke V, Witte T, Skripuletz T, Ernst D. Seeliger T, et al. Among authors: skripuletz t. J Neurol. 2023 Jun;270(6):2987-2996. doi: 10.1007/s00415-023-11613-5. Epub 2023 Feb 18. J Neurol. 2023. PMID: 36802030 Free PMC article.
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy.
Möhn N, Grote-Levi L, Hopfner F, Eiz-Vesper B, Maecker-Kolhoff B, Warnke C, Sühs KW, Wattjes MP, Höglinger GU, Skripuletz T. Möhn N, et al. Among authors: skripuletz t. J Neurol. 2022 May;269(5):2403-2413. doi: 10.1007/s00415-021-10952-5. Epub 2022 Jan 7. J Neurol. 2022. PMID: 34994851 Free PMC article. Review.
Editorial: Autoimmune complications of modern cancer therapies.
Möhn N, Renovanz M, Hagin D, Skripuletz T. Möhn N, et al. Among authors: skripuletz t. Front Immunol. 2024 Jan 5;14:1357825. doi: 10.3389/fimmu.2023.1357825. eCollection 2023. Front Immunol. 2024. PMID: 38250085 Free PMC article. No abstract available.
191 results